Astrana Health Inc (ASTH)vsEncompass Health Corp (EHC)
ASTH
Astrana Health Inc
$37.99
+0.37%
HEALTHCARE · Cap: $1.87B
EHC
Encompass Health Corp
$104.01
+4.18%
HEALTHCARE · Cap: $10.07B
Smart Verdict
WallStSmart Research — data-driven comparison
Encompass Health Corp generates 72% more annual revenue ($6.07B vs $3.53B). EHC leads profitability with a 10.0% profit margin vs 0.9%. EHC trades at a lower P/E of 17.4x. EHC earns a higher WallStSmart Score of 75/100 (B+).
ASTH
Buy56
out of 100
Grade: C
EHC
Strong Buy75
out of 100
Grade: B+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+89.9%
Fair Value
$188.57
Current Price
$37.99
$150.58 discount
Margin of Safety
-57.0%
Fair Value
$72.27
Current Price
$104.01
$31.74 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 55.6% year-over-year
Earnings expanding 110.1% YoY
Reasonable price relative to book value
Growing faster than its price suggests
Every $100 of equity generates 24 in profit
Attractively priced relative to earnings
Earnings expanding 30.3% YoY
Areas to Watch
Smaller company, higher risk/reward
ROE of 3.8% — below average capital efficiency
0.9% margin — thin
Operating margin of 3.0%
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : ASTH
The strongest argument for ASTH centers on Revenue Growth, EPS Growth, Price/Book. Revenue growth of 55.6% demonstrates continued momentum.
Bull Case : EHC
The strongest argument for EHC centers on PEG Ratio, Return on Equity, P/E Ratio. PEG of 0.41 suggests the stock is reasonably priced for its growth.
Bear Case : ASTH
The primary concerns for ASTH are Market Cap, Return on Equity, Profit Margin. A P/E of 61.7x leaves little room for execution misses. Thin 0.9% margins leave little buffer for downturns.
Bear Case : EHC
The primary concerns for EHC are Debt/Equity.
Key Dynamics to Monitor
ASTH profiles as a hypergrowth stock while EHC is a value play — different risk/reward profiles.
ASTH carries more volatility with a beta of 0.99 — expect wider price swings.
ASTH is growing revenue faster at 55.6% — sustainability is the question.
EHC generates stronger free cash flow (151M), providing more financial flexibility.
Bottom Line
EHC scores higher overall (75/100 vs 56/100). ASTH offers better value entry with a 89.9% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Astrana Health Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. The company is headquartered in Alhambra, California.
Encompass Health Corp
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Encompass Health Corporation offers in-home and post-acute health care services in the United States. The company is headquartered in Birmingham, Alabama.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?